Learoyd DL - Search Results

1

Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion.

O'Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS. O'Neill CJ, et al. Among authors: learoyd dl. Eur J Surg Oncol. 2011 Feb;37(2):181-5. doi: 10.1016/j.ejso.2010.11.005. Epub 2010 Dec 8. Eur J Surg Oncol. 2011. PMID: 21144693

2

Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.

Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M. Jayakody S, et al. World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8. World J Surg. 2018. PMID: 29484475

3

Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.

Learoyd DL, Roach PJ, Briggs GM, Delbridge LW, Wilmshurst EG, Robinson BG. Learoyd DL, et al. J Nucl Med. 1997 Feb;38(2):227-30. J Nucl Med. 1997. PMID: 9025742 Free article.

4

BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

Fraser S, Go C, Aniss A, Sidhu S, Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson B, Gill AJ, Sywak M. Fraser S, et al. World J Surg. 2016 Jul;40(7):1618-24. doi: 10.1007/s00268-016-3534-x. World J Surg. 2016. PMID: 27138882

5

Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma.

Kruijff S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, Clifton-Bligh RJ, Roach P, Gill AJ, Learoyd D, Sywak MS. Kruijff S, et al. Surgery. 2013 Dec;154(6):1337-44; discussion 1344-5. doi: 10.1016/j.surg.2013.06.034. Surgery. 2013. PMID: 24383104

6

Multiple endocrine neoplasia.

Learoyd DL, Delbridge LW, Robinson BG. Learoyd DL, et al. Aust N Z J Med. 2000 Dec;30(6):675-82. doi: 10.1111/j.1445-5994.2000.tb04362.x. Aust N Z J Med. 2000. PMID: 11198575 Review. No abstract available.

7

Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

Bullock M, O'Neill C, Chou A, Clarkson A, Dodds T, Toon C, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Learoyd DL, Capper D, von Deimling A, Clifton-Bligh RJ, Gill AJ. Bullock M, et al. Among authors: learoyd dl. Endocr Relat Cancer. 2012 Nov 9;19(6):779-84. doi: 10.1530/ERC-12-0239. Print 2012 Dec. Endocr Relat Cancer. 2012. PMID: 22997209

8

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.

Marsh DJ, Learoyd DL, Andrew SD, Krishnan L, Pojer R, Richardson AL, Delbridge L, Eng C, Robinson BG. Marsh DJ, et al. Among authors: learoyd dl. Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57. doi: 10.1046/j.1365-2265.1996.681503.x. Clin Endocrinol (Oxf). 1996. PMID: 8729519

9

Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.

Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG. Learoyd DL, et al. Arch Surg. 1997 Sep;132(9):1022-5. doi: 10.1001/archsurg.1997.01430330088015. Arch Surg. 1997. PMID: 9301617

10

RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.

Learoyd DL, Messina M, Zedenius J, Guinea AI, Delbridge LW, Robinson BG. Learoyd DL, et al. J Clin Endocrinol Metab. 1998 Oct;83(10):3631-5. doi: 10.1210/jcem.83.10.5152. J Clin Endocrinol Metab. 1998. PMID: 9768676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters